RB builds R&D on eight “science platforms”

1 March 2021 - Deborah Wilkes

Reckitt Benckiser (RB) is focusing on eight “science platforms” as it steps up investment in research and development across the organisation. The company says it is “doubling” the research and development spend for its OTC portfolio.